Company / CapEx per Share
Phathom Pharmaceuticals, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.04
FY2021-FY2025
Trend
-88.1%
vs FY2024
Sector context
#148 of 192
Health Care
What the data says
Phathom Pharmaceuticals, Inc.'s capex per share of $0.00 is lower than 77% of companies in the Health Care sector (FY2025). CapEx per Share has fluctuated over the past 7 years, ranging from $0.00 in FY2025 to $0.04 in FY2023.
Based on SEC 10-K filings.
0.00 in FY2025 with a 5-year CAGR of -36.1%.
Declined from $0.04 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -49.9%
- 5-Year CAGR
- -36.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 192This company $0.00 Sector average $2.46
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 88.1% year-over-year.
- Ranks #148 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -88.1% |
| FY2024 | $0.03 | -28.5% |
| FY2023 | $0.04 | +48.1% |
| FY2022 | $0.03 | +200.2% |
| FY2021 | $0.01 | -71.7% |
| FY2020 | $0.03 | +169.5% |
| FY2019 | $0.01 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026